|
|
|
|
LEADER |
04544nam a2200985Ia 4500 |
001 |
10-1016-j-ajoc-2022-101287 |
008 |
220420s2022 CNT 000 0 und d |
020 |
|
|
|a 24519936 (ISSN)
|
245 |
1 |
0 |
|a Netarsudil-associated reticular corneal epithelial edema
|
260 |
|
0 |
|b Elsevier Inc.
|c 2022
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.ajoc.2022.101287
|
520 |
3 |
|
|a Purpose: To describe 8 cases of reversible reticular corneal epithelial edema of the cornea that developed after use of the topical Rho-kinase inhibitor netarsudil. Methods: This is a retrospective chart review case series of 8 patients treated with netarsudil at an academic medical center. Observations: Patients had predisposing corneal conditions including penetrating keratoplasty, corneal decompensation after trabeculectomy-associated endophthalmitis, congenital glaucoma with Haab striae, aphakic bullous keratopathy, history of Ahmed valve and silicone oil, and Fuchs endothelial corneal dystrophy undergoing Descemet stripping only. One patient did not have clear predisposing corneal disease other than low endothelial cell density and a history of trabeculectomy. All patients developed reticular corneal epithelial edema, which appeared as collections of moderate sized superficial epithelial bullae arranged in a reticular pattern resembling a honeycomb. Most developed these changes within weeks of initiating netarsudil, but unique to this series are 2 cases in which netarsudil was tolerated by the cornea for months before developing reticular corneal epithelial edema after diode laser cyclophotocoagulation. In cases which underwent anterior segment optical coherence tomography, the imaging demonstrated that the corneal stroma was not edematous, and the reticular corneal epithelial edema involved both host and donor corneal epithelium in cases of penetrating keratoplasty. This fully resolved in all cases upon cessation of netarsudil, and this series is the first to document resolution via a pattern in which the individual bullae become smaller and more widely spaced apart. Conclusion: Netarsudil can cause a reversible reticular corneal epithelial edema. © 2022 The Authors
|
650 |
0 |
4 |
|a acetazolamide
|
650 |
0 |
4 |
|a adult
|
650 |
0 |
4 |
|a aged
|
650 |
0 |
4 |
|a aphakia
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a brimonidine
|
650 |
0 |
4 |
|a brimonidine plus brinzolamide
|
650 |
0 |
4 |
|a brimonidine plus timolol
|
650 |
0 |
4 |
|a case report
|
650 |
0 |
4 |
|a case study
|
650 |
0 |
4 |
|a cataract
|
650 |
0 |
4 |
|a cell density
|
650 |
0 |
4 |
|a central corneal thickness
|
650 |
0 |
4 |
|a clinical article
|
650 |
0 |
4 |
|a congenital glaucoma
|
650 |
0 |
4 |
|a cornea edema
|
650 |
0 |
4 |
|a cornea epithelium
|
650 |
0 |
4 |
|a cornea stroma
|
650 |
0 |
4 |
|a cornea transplantation
|
650 |
0 |
4 |
|a Corneal edema
|
650 |
0 |
4 |
|a Descemet membrane
|
650 |
0 |
4 |
|a disease predisposition
|
650 |
0 |
4 |
|a dorzolamide
|
650 |
0 |
4 |
|a dorzolamide plus timolol
|
650 |
0 |
4 |
|a drug substitution
|
650 |
0 |
4 |
|a drug withdrawal
|
650 |
0 |
4 |
|a endophthalmitis
|
650 |
0 |
4 |
|a endothelium cell
|
650 |
0 |
4 |
|a female
|
650 |
0 |
4 |
|a follow up
|
650 |
0 |
4 |
|a Fuchs endothelial dystrophy
|
650 |
0 |
4 |
|a glaucoma
|
650 |
0 |
4 |
|a graft rejection
|
650 |
0 |
4 |
|a Honeycomb edema
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a hyperpigmentation
|
650 |
0 |
4 |
|a intraocular pressure
|
650 |
0 |
4 |
|a keratopathy
|
650 |
0 |
4 |
|a laser coagulation
|
650 |
0 |
4 |
|a latanoprost
|
650 |
0 |
4 |
|a loteprednol etabonate
|
650 |
0 |
4 |
|a male
|
650 |
0 |
4 |
|a medical record review
|
650 |
0 |
4 |
|a middle aged
|
650 |
0 |
4 |
|a netarsudil
|
650 |
0 |
4 |
|a Netarsudil
|
650 |
0 |
4 |
|a open angle glaucoma
|
650 |
0 |
4 |
|a optical coherence tomography
|
650 |
0 |
4 |
|a patient comfort
|
650 |
0 |
4 |
|a patient history of surgery
|
650 |
0 |
4 |
|a penetrating keratoplasty
|
650 |
0 |
4 |
|a prednisolone
|
650 |
0 |
4 |
|a prednisolone acetate
|
650 |
0 |
4 |
|a pseudophakia
|
650 |
0 |
4 |
|a Reticular edema
|
650 |
0 |
4 |
|a retrospective study
|
650 |
0 |
4 |
|a Rhopressa
|
650 |
0 |
4 |
|a silicone oil
|
650 |
0 |
4 |
|a slit lamp microscopy
|
650 |
0 |
4 |
|a specular microscopy
|
650 |
0 |
4 |
|a stria
|
650 |
0 |
4 |
|a timolol
|
650 |
0 |
4 |
|a trabeculectomy
|
650 |
0 |
4 |
|a visual acuity
|
650 |
0 |
4 |
|a young adult
|
700 |
1 |
0 |
|a Chen, T.C.
|e author
|
700 |
1 |
0 |
|a Davies, E.C.
|e author
|
700 |
1 |
0 |
|a Jurkunas, U.V.
|e author
|
700 |
1 |
0 |
|a Lin, M.M.
|e author
|
700 |
1 |
0 |
|a Sola-Del Valle, D.A.
|e author
|
700 |
1 |
0 |
|a Tran, J.A.
|e author
|
700 |
1 |
0 |
|a Yin, J.
|e author
|
773 |
|
|
|t American Journal of Ophthalmology Case Reports
|